Pages that link to "Q44405507"
Jump to navigation
Jump to search
The following pages link to Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. (Q44405507):
Displaying 50 items.
- Antidepressants for smoking cessation (Q24201167) (← links)
- Antidepressants for smoking cessation (Q24245969) (← links)
- Antidepressants for smoking cessation (Q24246426) (← links)
- A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation (Q27335497) (← links)
- The Past, Present, and Future of Nicotine Addiction Therapy (Q28088508) (← links)
- Nicotine and endogenous opioids: Neurochemical and pharmacological evidence (Q28111990) (← links)
- Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status (Q28280398) (← links)
- Negative affective states and cognitive impairments in nicotine dependence (Q30371220) (← links)
- Don't stress about CRF: assessing the translational failures of CRF1antagonists (Q30399543) (← links)
- Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal (Q30448787) (← links)
- Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats (Q30476918) (← links)
- Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice (Q30478971) (← links)
- Varenicline improves mood and cognition during smoking abstinence (Q30483957) (← links)
- Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research (Q30485478) (← links)
- Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice (Q30489401) (← links)
- Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal (Q33566228) (← links)
- Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose. (Q33616676) (← links)
- Psychological mediators of bupropion sustained-release treatment for smoking cessation (Q33887773) (← links)
- Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice (Q34128836) (← links)
- Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics (Q34157674) (← links)
- Reward, Addiction, Withdrawal to Nicotine (Q34173418) (← links)
- The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. (Q34412607) (← links)
- Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. (Q34602596) (← links)
- Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats (Q34696292) (← links)
- Bupropion improves attention but does not affect impulsive behavior in healthy young adults (Q34732652) (← links)
- Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment (Q34982402) (← links)
- Bupropion-varenicline interactions and nicotine self-administration behavior in rats (Q35091751) (← links)
- Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: Results from a randomized, double-blind, placebo-controlled study (Q35124169) (← links)
- Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. (Q35184641) (← links)
- Tobacco use and cessation for cancer survivors: an overview for clinicians (Q35226577) (← links)
- Cigarette smoking, nicotine, and body weight (Q35369070) (← links)
- Modeling anxiety using adult zebrafish: A conceptual review (Q35375608) (← links)
- Reinforcer devaluation as a consequence of acute nicotine exposure and withdrawal (Q35417501) (← links)
- Voluntary running-wheel exercise decreases the threshold for rewarding intracranial self-stimulation (Q35611053) (← links)
- Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion (Q35613704) (← links)
- Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies (Q35694111) (← links)
- Biomarkers to Optimize the Treatment of Nicotine Dependence (Q35773685) (← links)
- Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats (Q35913833) (← links)
- Extending the role of associative learning processes in nicotine addiction (Q36011360) (← links)
- Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats (Q36021414) (← links)
- The dopamine hypothesis of drug addiction: hypodopaminergic state. (Q36083476) (← links)
- Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning (Q36103496) (← links)
- Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior? (Q36181354) (← links)
- Nicotine as a typical drug of abuse in experimental animals and humans. (Q36277268) (← links)
- Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. (Q36323545) (← links)
- Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse (Q36349942) (← links)
- Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats (Q36432323) (← links)
- Therapeutic advances in the treatment of nicotine addiction: present and future (Q36443676) (← links)
- Bupropion for the treatment of nicotine withdrawal and craving (Q36532139) (← links)
- The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats (Q36534965) (← links)